Diabetic Macular Edema Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
AMPE | F | Ampio Pharmaceuticals, Inc. | 0.00 | |
KALV | F | KalVista Pharmaceuticals, Inc. | 4.07 | |
OPT | F | Opthea Limited | -1.07 | |
EYPT | D | EyePoint Pharmaceuticals, Inc. | -6.76 | |
RZLT | C | Rezolute, Inc. | -2.99 | |
ALIM | C | Alimera Sciences, Inc. | 0.00 | |
OCS | C | Oculis Holding AG | -1.07 | |
EPRX | B | Eupraxia Pharmaceuticals Inc. | -6.39 |
Related Industries: Biotechnology Drug Manufacturers - Major Shell Companies
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
XPH | B | SPDR S&P Pharmaceuticals ETF | 0.94 | |
PILL | C | Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF | 0.65 | |
QQQS | C | Invesco NASDAQ Future Gen 200 ETF | 0.39 | |
IWC | B | iShares Microcap ETF | 0.26 | |
IBBQ | D | Invesco Nasdaq Biotechnology ETF | 0.09 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Nov 15 | OPT | Opthea Appoints Kathy Connell to Board of Directors |
- Diabetic Macular Edema
Diabetic retinopathy, also known as diabetic eye disease, is a medical condition in which damage occurs to the retina due to diabetes mellitus. It is a leading cause of blindness.Diabetic retinopathy affects up to 80 percent of those who have had diabetes for 20 years or more. At least 90% of new cases could be reduced with proper treatment and monitoring of the eyes. The longer a person has diabetes, the higher his or her chances of developing diabetic retinopathy. Each year in the United States, diabetic retinopathy accounts for 12% of all new cases of blindness. It is also the leading cause of blindness in people aged 20 to 64.
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles